Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04883736Phase 1Completed
Phase 1, randomised, double-blind trial of tretinoin in acne vulgaris (3 arms). Primary endpoint: Percentage change in the inflammatory and non-inflammatory lesion counts at 12 weeks. Started Aug 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04883736.